Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent.

Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent.
复制标题

细胞相关的 HIV-1 在小鼠体内的阴道传播可被局部膜修饰剂阻断。

DOI:
10.1172/jci13236
复制
发表时间:
2002
期刊:
The Journal of clinical investigation
影响因子:
--
通讯作者:
Markham,RichardB
Markham,RichardB
中科院分区:
--
文献类型:
--
作者:
Khanna,KristenV;Whaley,KevinJ;Zeitlin,Larry;Moench,ThomasR;Mehrazar,Karim;Cone,RichardA;Liao,Zhaohao;Hildreth,JamesEK;Hoen,TimothyE;Shultz,Leonard;Markham,RichardB

文献摘要

被引文献

相似文献

由于HIV-1病毒粒子和HIV感染细胞都存在于受感染个体的精液和宫颈粘液中,因此HIV-1预防策略必须考虑无细胞病毒和细胞相关病毒。靶向HIV-1病毒体的抗体已被证明可以防止猕猴中无细胞病毒的阴道传播,但由于细胞相关传播尚未在该模型系统中得到可靠证明,因此尚未测试预防此类传播的策略。我们采用了一种小鼠模型,其中SCID小鼠携带人外周血白细胞(HuPBL)。在这些小鼠中,通过HIV感染细胞的跨上皮迁移介导,发生细胞相关但非无细胞的HIV-1传播的阴道传播。β-环糊精(β-CD)是一种胆固醇螯合剂,可干扰细胞迁移和病毒从脂筏出芽,局部应用可阻断细胞相关HIV-1的传播。HIV-1阴道传播的HuPBL-SCID模型应被证明可用于研究细胞相关HIV-1经粘膜HIV-1传播,以及用于筛选预防HIV-1性传播的潜在有效性的试剂。
Because both HIV-1 virions and HIV-infected cells are present in the semen and cervical mucus of infected individuals, HIV-1 prevention strategies must consider both cell-free and cell-associated virus. Antibodies that target HIV-1 virions have been shown to prevent vaginal transmission of cell-free virus in macaques, but since cell-associated transmission has not been reliably demonstrated in this model system, no strategies to prevent such transmission have been tested. We have employed a mouse model in which SCID mice carry human peripheral blood leukocytes (HuPBLs). In these mice, vaginal transmission of cell-associated, but not cell-free, HIV-1 transmission occurs, mediated by transepithelial migration of HIV-infected cells. Topical application of β-cyclodextrin (β-CD), a cholesterol-sequestering agent that interferes with cell migration and budding of virus from lipid rafts, blocks transmission of cell-associated HIV-1. The HuPBL-SCID model of vaginal HIV-1 transmission should prove useful for investigating cell-associated HIV-1 transmucosal HIV-1 transmission, as well as for screening reagents for their potential efficacy in preventing sexual HIV-1 transmission.